Clinical Trial Update: 4-PBA: Will it Increase the Level of Alpha 1-Antitrypsin(AAT) in Persons With AAT Deficiency? [Phase 2]

View source ↗

Summary

This update notes the Phase 2 trial of 4-phenylbutyrate to raise alpha-1 antitrypsin levels in individuals with alpha-1 antitrypsin deficiency has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alpha-1 Antitrypsin Deficiency

Drugs mentioned

• 4-phenylbutyrate (4-phenylbutyrate)

Snippet

Sponsor: University of Florida | Conditions: Alpha 1-Antitrypsin Deficiency | Phase 2 | Status: COMPLETED